The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Screening and cervical cancer cure: population based cohort study
Open accessAbstract
OBJECTIVE: To determine whether detection of invasive cervical cancer by screening results in better prognosis or merely increases the lead time until death. DESIGN: Nationwide population based cohort study. SETTING: Sweden. PARTICIPANTS: All 1230 women with cervical cancer diagnosed during 1999-2001 in Sweden prospectively followed up for an average of 8.5 years. MAIN OUTCOME MEASURES: Cure proportions and five year relative survival ratios, stratified by screening history, mode of detection, age, histopathological type, and FIGO (International Federation of Gynecology and Obstetrics) stage. RESULTS: In the screening ages, the cure proportion for women with screen detected invasive cancer was 92% (95% confidence interval 75% to 98%) and for symptomatic women was 66% (62% to 70%), a statistically significant difference in cure of 26% (16% to 36%). Among symptomatic women, the cure proportion was significantly higher for those who had been screened according to recommendations (interval cancers) than among those overdue for screening: difference in cure 14% (95% confidence interval 6% to 23%). Cure proportions were similar for all histopathological types except small cell carcinomas and were closely related to FIGO stage. A significantly higher cure proportion for screen detected cancers remained after adjustment for stage at diagnosis (difference 15%, 7% to 22%). CONCLUSIONS: Screening is associated with improved cure of cervical cancer. Confounding cannot be ruled out, but the effect was not attributable to lead time bias and was larger than what is reflected by down-staging. Evaluations of screening programmes should consider the assessment of cure proportions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kosary, C. L. (1994) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980100107 · Cited by 417
Cited by
Landy, R., Pesola, F., Castañón, A., & Sasieni, P. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.290 · Cited by 379
Verdoodt, F., Jentschke, M., Hillemanns, P., Racey, C. S., Snijders, P. J. F., & Arbyn, M. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.006 · Cited by 275
HPV testing as a screen for cervical cancer
Goodman, A. (2015) · BMJ · doi:10.1136/bmj.h2372 · Cited by 262
Jansen, E. E. L., Zielonke, N., Gini, A., Anttila, A., Segnan, N., Vokó, Z., Ivanuš, U., McKee, M., de Koning, H. J., de Kok, I. M. C. M., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2019.12.013 · Cited by 258
Simms, K. T., Keane, A., Nguyen, D. T. N., Caruana, M., Hall, M. T., Lui, G., Gauvreau, C., Demke, O., Arbyn, M., Basu, P., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02600-4 · Cited by 105
Metadata
- Authors
- Andrae, B., Andersson, T. M.-L., Lambert, P. C., Kemetli, L., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., Tornberg, S., & Sparen, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2012-03-01
- Volume
- 344
- Issue
- mar01 2
- Pages
- e900-e900
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2010865756
- Cited by
- 208
- References
- 1
- FWCI
- 15.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening and cervical cancer cure: population based cohort study. https://app.cochat.ai/papers/10.1136/bmj.e900
- The paper
- Andrae, B., Andersson, T. M.-L., Lambert, P. C., Kemetli, L., Silfverdal, L., Strander, B., Ryd, W., Dillner, J., Tornberg, S., & Sparen, P. (2012). Screening and cervical cancer cure: population based cohort study. BMJ. https://doi.org/10.1136/bmj.e900
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.